Research library
Prepared by Pillar Research
PT-141
Sources and editorial policyA synthetic melanocortin-receptor agonist studied for its activity at central MC3R/MC4R signalling pathways.
Evidence limits
Published findings describe specific animal-model and controlled human-pharmacology study contexts. This reference is a research summary only; it does not describe, endorse, or provide dosing or administration information for any pharmaceutical product.
Sources
For current strength, AUD price, purity, batch COA and Australian dispatch, see PT-141 10mg (PT-141 Peptide) product specifications.